Beyond correlation: Intraclass correlation and bland-altman analysis reveal poor absolute agreement across multiplex cytokine immunoassay platforms
Abstract
Cross-platform comparisons of serum cytokine immunoassays have often focused on rank correlation, but the extent of absolute agreement and systematic bias between platforms remains insufficiently characterized. Few independent head-to-head evaluations have compared multiple immunoassay platforms on the same clinical samples using overlapping cytokines. Here, serum samples from 48 adult participants were analyzed in parallel for seven cytokines (IL-6, IL-7, IL-8, IL-10, IL-15, TNF-α, IFN-γ), four chemokines (CCL2, CCL3, CCL4, CXCL10), and one growth factor (VEGF-A) using three multiplex platforms: OLINK proximity extension assay-based, LUMINEX bead-based, and V-PLEX electrochemiluminescence-based immunoassays. LLOQs, absolute concentrations, rank correlations, ICCs, and Bland-Altman biases were compared between platforms. Absolute serum cytokine concentrations differed by up to two orders of magnitude. Correlations between OLINK and V-PLEX were generally strong, whereas correlations involving LUMINEX were often weak or non-significant. ICCs were poor (<0.5) for most analytes and platform pairs, with IL-8 as a notable exception. Bland-Altman analyses on log-transformed concentrations revealed large, analyte-specific multiplicative biases and wide ratio-scale limits of agreement, indicating poor absolute agreement. These findings show that OLINK, LUMINEX, and V-PLEX measurements are not interchangeable at the level of absolute concentrations and underscore key analytical limitations that currently hinder the broad adoption of cytokine immunoassays, particularly multiplex panels, as regulator-approved tests.
// Source
Authors: Olfa Khalfallah, Cynthia Le Mouroux, Narjis Kraïmi, Claire Sendra, Nathalie Saint‐Laurent, Maryline Guidetti, Laurence Pellegrina, Fanchon Herman, Nicolas Molinari, Raoul Belzeaux, Nicolas Glaichenhaus, Laetitia Davidovic
Institutions: Inserm, Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire de Montpellier, Université de Montpellier, Centre de Recherches en Cancérologie de Toulouse, Institut de Génomique Fonctionnelle, Institute for Neurosciences of Montpellier, Institut de Pharmacologie Moléculaire et Cellulaire, Eurofins (France)